Bellevue Group AG公司增加了在Natera医疗公司的股权,该公司目前持有价值超过2 300万美元的股份。 Bellevue Group AG boosted its stake in medical firm Natera, now holding shares worth over $23 million.

Bellevue集团股份集团在第四季度将Natera公司的股份增加5.2%,现在拥有145 676股,价值2 306万美元。 Bellevue Group AG increased its holdings in Natera, Inc. by 5.2% in the fourth quarter, now owning 145,676 shares valued at $23.06 million. Natera是一家医学研究公司,市场上限为211.8亿美元,报告负净差14.01%,收入4.7610亿美元,超过分析师的预期。 Natera, a medical research company with a market cap of $21.18 billion, reported a negative net margin of 14.01% and revenue of $476.10 million, surpassing analyst expectations. Kovitz投资集团在同一期间还购买了1 335股股票。 Kovitz Investment Group also bought 1,335 shares during the same period.